Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.0%

3 terminated out of 25 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (8)
P 1 (3)
P 2 (3)
P 3 (1)

Trial Status

Completed9
Unknown6
Recruiting4
Terminated3
Active Not Recruiting2
Suspended1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT06181201TerminatedPrimary

Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer

NCT04095299Phase 3RecruitingPrimary

Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients

NCT05358704Phase 2SuspendedPrimary

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT05732389Phase 2RecruitingPrimary

Immunotherapy in Patients With Early dMMR Rectal Cancer

NCT05179824Active Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT06940778Active Not RecruitingPrimary

LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

NCT03573791Recruiting

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

NCT05887531Not ApplicableCompleted

Abdominopelvic Cancer Prehabilitation

NCT03133286Completed

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

NCT04812743Not ApplicableTerminated

Colorectal Health Research Champions

NCT04880772Not ApplicableCompleted

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

NCT04716010Not ApplicableCompleted

Developing and Evaluating Product Messaging

NCT04319354Not ApplicableCompletedPrimary

Evaluation of cfDNA as a Marker of Response in Rectal Cancer

NCT04160650Not ApplicableCompleted

Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy

NCT02948348Phase 1UnknownPrimary

Study to Nivolumab Following Preoperative Chemoradiotherapy

NCT02641691Phase 2CompletedPrimary

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum

NCT03896958Unknown

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

NCT03996031Completed

Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic

NCT04456283UnknownPrimary

Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy

Scroll to load more

Research Network

Activity Timeline